HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Christopher G.A. McGregor Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yap, J. Articles by McGregor, C. G.A. Search for Related Content PubMed PubMed Citation Articles by Yap, J. Articles by McGregor, C. G.A. Related Collections Molecular biology Transplantation - heart

Eur J Cardiothorac Surg 2001;19:702-707
© 2001 Elsevier Science NL

Conditions of vector delivery improve efficiency of adenoviral-mediated gene transfer to the transplanted heart

^a Department of Surgery, Mayo Clinic and Foundation, Rochester, MN 55905, USA
^b Division of Endocrinology and Metabolism, Mayo Clinic and Foundation, Rochester, MN 55905, USA
^c Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN 55905, USA

Received 18 August 2000; received in revised form 12 February 2001; accepted 9 March 2001.

Corresponding author. Tel.: +1-507-255-6038; fax: +1-507-255-4500
e-mail: mcgregor.christopher{at}mayo.edu

Objectives: Conditions for ex vivo gene transfer to the transplanted heart were studied in a model of syngeneic abdominal heterotopic heart transplantation in the rat. Various methods of adenoviral-mediated gene transfer to the transplanted heart were compared. Methods: In the first experiment, a dose response study, an adenoviral vector encoding the ß-galactosidase gene was infused into the donor heart with the pulmonary artery open and flushed out prior to performing the transplant. In the second experiment, the effects of clamping the pulmonary artery during vector infusion and not flushing out the viral solution, resulting in vector dwell during the warm ischemia, were examined. Results: In the first experiment, gene transfer was relatively inefficient; however, transgene expression improved with increases in the vector dose (range, 1x10⁷–1x10⁹). The efficiency of gene transfer was significantly greater when the conditions of the second experiment were applied. In all models studied, cardiomyocytes and not vascular endothelial cells were the predominant cell type transduced. Conclusions: This study indicates that the conditions of adenoviral vector delivery are critical for optimizing gene transfer in the transplant setting. In addition, intravascular administration of adenoviral vector to the donor heart results predominantly in cardiomyocyte transgene expression.

Key Words: Adenovirus • Gene therapy • Gene transfer • Heart • Transplantation

This article has been cited by other articles:

				D. Ricci, A. A. Mennander, L. D. Pham, V. P. Rao, N. Miyagi, G. W. Byrne, S. J. Russell, and C. G.A. McGregor Non-invasive radioiodine imaging for accurate quantitation of NIS reporter gene expression in transplanted hearts Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 32 - 39. [Abstract] [Full Text] [PDF]